Safe to stop anticoagulants three months after VTE linked to COVID-19, study suggests
Doctors reported fewer than 40 recurrences in the year following discontinuation, among 1100 patients.
Long-term anticoagulation may be unnecessary in patients with COVID-19-associated VTE, with doctors reporting low rates of recurrence after stopping therapy.
Their study of 1100 adults suggests that three months of anticoagulation is sufficient to ward off VTE recurrences.
